| Document |
Document Title |
|
WO/2020/084846A1 |
[4-Methoxymethyl)-2,3,6-trifluorophenyl]methyl 2,2-dimethyl-3-((Z)-1-propenyl)cyclopropanecarboxylate has an excellent controlling effect on ixodid ticks and, therefore, is usable as an active ingredient of a composition for controlling ...
|
|
WO/2020/084847A1 |
[4-(methoxymethyl)-2,3,5-trifluorophenyl]methyl 2,2-dimethyl-3-((Z)-1-propenyl)cyclopropane carboxylate is effective at controlling plant diseases, and can therefore be used an active ingredient in an agent for controlling plant diseases...
|
|
WO/2020/084266A1 |
The invention relates to biobased anti-UV molecules. In particular, the invention relates to a novel process for preparing b-b dimers having anti-UV and antioxidant properties, from p-hydroxycinnamic esters and amides disubstituted in th...
|
|
WO/2020/082200A1 |
The invention relates to a carbonylation catalyst for synthesizing an oxalate from carbon monoxide (CO) and nitrite in a gas phase is provided. The catalyst comprises an active component, an auxiliary agent and a carrier. The active comp...
|
|
WO/2020/085373A1 |
The present invention provides a novel compound which has activating activity selective for ERβ. A compound represented by formula (1) or a salt thereof. (In the formula, R1 represents a cycloalkyl group having 3-8 carbon atoms, an alke...
|
|
WO/2020/084599A2 |
The present invention relates to ammonium salts of partially fluorinated organic acids, represented by the general formula 1. The present invention relates also to a synthesis method of said salts as well as its use to the production of ...
|
|
WO/2020/082199A1 |
The invention relates to a catalyst for synthesizing an oxalate by a CO coupling reaction. The catalyst comprises an active component, an auxiliary agent and hollow microspheres of α-Al2O3 as a carrier. The auxiliary agent may comprise ...
|
|
WO/2020/081116A1 |
Injectable or topical pharmaceutical composition comprising compounds (I), (III) or (II) are provided, wherein -R2 is a straight or branched polymeric moiety; -R1, -R4- and -Rx are independently selected from linkers that are capable of ...
|
|
WO/2020/081836A1 |
The present disclosure provides compounds and compositions capable of extending lifespan, and methods of use thereof.
|
|
WO/2020/079007A1 |
The present invention relates to the use of an ether or an ester of a 1 -substituted cycloalkanol or of mixtures of two or more ethers or esters of 1 -substituted cycloalkanols or of a stereoisomer thereof or of a mixture of two or more ...
|
|
WO/2020/080157A1 |
The present invention addresses the problem of providing a novel compound which suppresses volatilization of a curing agent during a curing reaction, thereby enabling the achievement of a curing agent that has excellent characteristics s...
|
|
WO/2020/078369A1 |
Provided are a phenolic derivative, preparation method therefor and use thereof. The phenolic derivative has a structure as shown in formula (I), and the definitions of the groups therein are shown in the description. The phenolic deriva...
|
|
WO/2020/078204A1 |
A method for preparing 3-hydroxy-6-oxohexanoate. In the method, haloacetaldehyde acetal is used as the starting material, and is subjected to Grignardation and nucleophilic substitution reaction to obtain key epoxide intermediates; then ...
|
|
WO/2020/080120A1 |
Provided is a polar compound having high chemical stability, high ability to orient liquid crystal molecules, high solubility with respect to a liquid crystal composition, and a high voltage holding ratio of a liquid crystal display elem...
|
|
WO/2020/079011A1 |
The present invention relates to the use of an ether or an ester of a tertiary alkanol or of mixtures of two or more ethers or esters of tertiary alkanols or of a stereoisomer thereof or of a mixture of two or more stereoisomers thereof ...
|
|
WO/2020/080894A1 |
The present invention relates to a novel crosslinker compound and a superabsorbent polymer prepared using same. More specifically, the present invention relates to a crosslinker compound which exhibits excellent crosslinking properties a...
|
|
WO/2020/076920A1 |
The present disclosure provides compositions and methods for metathesizing a first alkenyl or alkynyl group with a second alkenyl or alkynyl group, the composition comprising a ruthenium metathesis catalyst and a photoredox catalyst that...
|
|
WO/2020/077094A1 |
The invention generally relates to non-oral formulations of TCA cycle intermediates and methods of using such formulations for treating metabolic disorders. In certain embodiments, the invention provides therapeutic compositions containi...
|
|
WO/2020/074945A1 |
The present invention provides a plasticizer for vinyl chloride resins which has good compatibility with vinyl chloride resins, and further which may be used to provide a vinyl chloride resin composition capable of being formed into an a...
|
|
WO/2020/075764A1 |
Provided is a compound that inhibits the activity of TRPV4, and that is useful in the prevention or amelioration of overactive bladder, irritable bowel syndrome, and the like. This TRPV4 activity inhibitor comprises, as an active ingre...
|
|
WO/2020/063892A1 |
Disclosed is an industrial method for simultaneously preparing stevia rebaudiana chlorogenic acid and stevioside. The industrial method includes carrying out alcohol extraction on stevia rebaudiana which is used as a raw material, and th...
|
|
WO/2020/067391A1 |
The present invention addresses the problem of providing a production method that is for a polycyclic dicarboxylic acid monoester and comprises collecting a polycyclic dicarboxylic acid existing as an unreacted raw material or impurity, ...
|
|
WO/2020/069176A1 |
A substrate composition for leukocyte esterases comprising a monoester, said monoester being one of an α-amino acid ester or an α-hydroxy acid ester, with specificity for leukocyte esterases, said monoester having a first moiety for pa...
|
|
WO/2020/059634A1 |
The purpose of the present invention is to provide an intermediate production method capable of efficiently producing an intermediate containing a compound (I) at a high concentration. An intermediate production method according to the p...
|
|
WO/2020/059625A1 |
Provided is a thermosetting resin composition that makes it possible to obtain a cured product that maintains a substantially low dielectric constant but also has a substantially low dielectric loss tangent, even for high-speed, high-fre...
|
|
WO/2020/059768A1 |
The present invention provides a halogen compound that can be advantageously used for production of a 1,1-disubstituted hydrazine compound and preparation of a polymerizable compound. A compound according to the present invention is repr...
|
|
WO/2020/059824A1 |
A method for producing a boron-containing conjugated polyene compound, the method being provided with a step for reacting a first raw material compound that has a carbon-carbon triple bond and a second raw material compound that has a 1,...
|
|
WO/2020/056564A1 |
Disclosed is a method for preparing a 1,3-dicarbonyl compound based on a metal hydride/palladium compound system. The method comprises the following steps: suspending a palladium compound and a metal hydride in a solvent under the protec...
|
|
WO/2020/058725A2 |
A method for preparing a partially fluorinated ester comprising acyl and alkoxy groups wherein the acyl group comprises a branched or linear fluorine containing C3-C8 group with one of the structures: (Formulae (I), (II)) wherein X and Y...
|
|
WO/2020/056565A1 |
Provided is an application of a metal hydride/palladium compound system in the preparation of a 1,3-dicarbonyl compound in a cascade reaction of an electron-deficient alkene compound, said reaction comprising the following steps: under t...
|
|
WO/2020/059624A1 |
Provided are: a monofunctional phenol compound that makes it possible to obtain an active ester resin that makes it possible to form a cured product that has excellent dielectric characteristics and heat resistance; an active ester resin...
|
|
WO/2020/051855A1 |
Disclosed are a reduction method and reduction product of an alkenyl active methylene compound. The reduction reaction comprises the following steps: taking an alkenyl active methylene compound as a substrate, a metal hydride as a reduci...
|
|
WO/2020/055739A1 |
Provided are compositions and methods for treating multiple sclerosis (MS). One embodiment of the disclosed method entails orally administering to a MS patient a first amount of a nonsteroidal anti-inflammatory drug (NSAID), such as aspi...
|
|
WO/2020/054874A1 |
[Problem] To provide a photopolymerization sensitizer which exhibits sufficient photocuring speed during practical use, without causing problems such as staining or powder on the cured article or the appearance of an additive such as the...
|
|
WO/2020/054116A1 |
[Problem] To provide a photopolymerization sensitizer which exhibits sufficient photocuring speed during practical use, without causing problems such as staining or powder on the cured article or the appearance of an additive such as the...
|
|
WO/2020/050339A1 |
Provided is an industrially useful method for manufacturing (1R,2S)-2-{[((2,4-dimethylpyrimidine-5-yl)oxy}methyl]-2-(3-f
luorophenyl)-N-(5-fluoropyridine-2-yl)cyclopropane-1-carboxa
mide. In the present invention, (1R,2S)-2-{[((2,4-dimet...
|
|
WO/2020/048592A1 |
What is described is an emulsifier comprising or consisting of one or more different compound(s) of the formula (I), in each of which, in particular: R1, R2 and R3 are each independently (i) a hydrogen atom, (ii) a fatty acid residue bon...
|
|
WO/2020/050977A1 |
A method for preparing a hydrocarbylhydrocarbyloxysilane of formula RaHpSi(OR)(4-a-b),, where each R is independently a hydrocarbyl group and subscript a is 1 to 4 and subscript b is 1 to 2 is disclosed. The method includes heating ingre...
|
|
WO/2020/049077A1 |
What is described is an emulsifier comprising or consisting of a mixture of compound(s) of the formula (I), in each of which, in particular: R1, R2 and R3 are each independently (i) a hydrogen atom, (ii) a fatty acid residue bonded to th...
|
|
WO/2020/050322A1 |
The present invention addresses the problem of providing: a compound which increases in HTP upon exposure to light by irradiation with, for example, ultraviolet light; and a mixture containing the compound. The present invention further ...
|
|
WO/2020/050271A1 |
The present invention relates to: a transition metal complex having a PNNP4 ligand that is easily manufactured and handled and that is relatively inexpensive to procure, and a method for manufacturing the same; a method for performing hy...
|
|
WO/2020/048957A1 |
Disclosed herein is a photosensitive composition comprising a) at least one photoacid generator; b) at least one Novolak polymer; c) at least one acrylate polymer, comprising a component having structure (I); d) at least one glycidyl hyd...
|
|
WO/2020/049502A1 |
Catalyst compositions comprising catalytic nanoparticles including copper distributed, dispersed on, or mixed with a promoter including magnesium oxide. Pre-catalyst compositions comprising nanoparticles including copper oxides or copper...
|
|
WO/2020/049957A1 |
The present invention provides a compound having an excellent rate of HTP change by exposure to light. In addition, the present invention provides a composition, a cured product, an optically anisotropic body, and a reflective film, whic...
|
|
WO/2020/050368A1 |
The purpose of the present invention is to provide: a method for preparing a Vilsmeier reagent, that can be carried out safely, easily, and at a low cost; and a method for producing an aromatic aldehyde or an aromatic ketone, a carboxyli...
|
|
WO/2020/041871A1 |
This application is directed to the use of a ketogenic agent, such as 1,3-butanediol, R-β-hydroxybutyl-R-β-hydroxybutyrate, or triheptanoin, in the treatment of an individual having a lysosomal storage disease, including Pompe disease....
|
|
WO/2020/042766A1 |
A GABA A receptor allosteric enhancer compound and preparation and a use thereof are disclosed. The compound has a structure represented by formula (1). R 1 and R 2 are each independently selected from isopropyl and n-propyl; and when R ...
|
|
WO/2020/039297A1 |
The present invention relates to the novel compounds of Formula I, and salts thereof and use of said compounds as intermediates for the preparation of (E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-
en-1-yl)phenoxy)-2-methyl...
|
|
WO/2020/040161A1 |
Provided is a composition containing a polyphenol compound (B), wherein the polyphenol compound (B) is one or more resins selected from the group consisting of resins having the structure represented by formula (1) and resins having the ...
|
|
WO/2020/040162A1 |
Provided is a composition containing a polyphenol compound (B), wherein the polyphenol compound (B) is one or more substances selected from the group consisting of compounds having the structure represented by formula (1) and resins havi...
|
